Arecor Therapeutics Plc

Arecor Therapeutics (AREC)

Company name:Arecor Therapeutics Plc
EPIC:ARECTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BMWLM973
Market Segment:ASQ1Share Type:DE
WWW Address: GBP0.01
 Price Price Change [%] Bid Offer Open High Low Volume
 335.00 -15.0 [-4.29] 320.00 350.00 350.00 350.00 335.00 1,600
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 93.25 27.84 0.33 -0.27 - - - 460.00 - 226.00

Arecor Therapeutics Key Figures

(at previous day's close)
Market Cap.93.25m
Shares In Issue27.84m
Prev. Close350.00
PE Ratio- 
Dividend Yield-%
EPS - basic-0.27p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-19.58p
Return On Equity (ROE)-33.26%
Operating Margin-599.74%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt-15.94m
Gross Gearing11.34%
Quick Assets20.56m
Net Working Capital18.30m
Intangibles / Fixed Assets8.38%
Turnover PS4.16p
Pre-Tax Profit PS-24.95p
Retained Profit PS-22.16p
Cash PS65.80p
Net Cash PS57.66p
Net Tangible Asset Value PS *66.53p
Net Asset Value PS66.64p
Spread30.00 (8.57%) 

Arecor Therapeutics Balance Sheet


Share Price Performance

Sample Period HighLow
1 week370.00335.00
4 weeks380.00335.00
12 weeks420.00335.00
1 year460.00226.00

Share Price Chart (5 years)

Arecor Therapeutics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week370.00-35.00-9.46335.000.00351.70
4 weeks380.00-45.00-11.84335.000.00355.94
12 weeks385.00-50.00-12.99335.000.00389.97
26 weeks400.00-65.00-16.25315.000.00376.13
1 year237.5097.5041.05226.000.01328.10
3 years237.5097.5041.05226.000.01307.18
5 years237.5097.5041.05226.000.01307.18

Arecor Therapeutics Key Management Ratios

Arecor Therapeutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 4.46 
Tobin's Q Ratio (excl. intangibles)4.46 
Dividend Yield-%
Market-to-Book Ratio5.03 
Price-to-Pre-Tax Profit PS-13.43 
Price-to-Retained Profit PS-15.12 
Price-to-Cash Flow PS-17.11 
Price-to-Sales PS80.52 
Price-to-Net Tangible Asset Value PS5.04 
Price-to-Cash PS5.09 
Net Working Capital PS65.73 
Price Pct to Working Capital PS5.10%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Arecor Therapeutics Financial Ratios

(Leverage Ratios)
Debt Ratio0.56%
Debt-to-Equity Ratio0.01 
Debt-to-Equity Ratio (excl. Intgbl)0.01 
Debt-to-Equity Market Value0.00 
Net Gearing-76.21%
Net Gearing (excl. Intangibles)-76.32%
Gross Gearing11.34%
Gross Gearing (excl. Intangibles)11.35%
Gearing Under 1 Year10.84%
Gearing Under 1 Year (excl. Intgbl)10.85%
(Liquidity Ratios)
Net Working Capital to Total Assets87.45%
Current Ratio9.07 
Quick Ratio (Acid Test)9.07 
Liquidity Ratio8.08 
Cash & Equiv/Current Assets89.07%
(Solvency Ratios)
Enterprise Value75.04m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.03 
Total Debt/Sales2.05 
Total Debt/Pre-Tax Profit-0.34 
Total Debt2.37m
Total Debt/Net Current Assets0.13%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)

Arecor Therapeutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-37.23%
Return On Assets (ROA)-29.49%
Net Profit Margin-532.73%
Assets Turnover0.06 
Return On Equity (ROE)-33.26%
Return On Investment (ROI)-33.07%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-532.73%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.06 
Fixed Assets Turnover3.23 
Current Assets Turnover0.06 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales18.07 
Debt Collection Period708.25Days

Arecor Therapeutics Dividends

Sorry No Data Available

Arecor Therapeutics Fundamentals

 31 Dec 2021 (GBP)
pre tax profit-6.95-599.74%m
attributable profit-6.17-532.73%m
retained profit-6.17-532.73%m
eps - basic (p)-0.27 
eps - diluted (p)-0.27 
dividends per share- 

Arecor Therapeutics Balance Sheet

 31 Dec 2021 (GBP)
 31 Dec 2021 (GBP)
fixed assets fixed assets0.331.57%m
intangibles intangibles0.030.14%m
fixed investments fixed investments--%m
current assets - other current assets - other--%m
stocks stocks--%m
debtors debtors2.2510.74%m
cash & securities cash & securities18.3287.55%m
creditors - short creditors - short2.2710.84%m
creditors - long creditors - long0.110.50%m
creditors - other creditors - other--%m
subordinated loans subordinated loans--%m
insurance funds insurance funds--%m
ord cap, reserves ord cap, reserves18.5588.66%m
prefs, minorities prefs, minorities--%m
NAV Basic- 
NAV Diluted- 

Arecor Therapeutics Cash Flow Statement

31 Dec 2021 (GBP)
Operating CF-5.45m
Pre-Financing CF-5.52m
Retained CF15.41m

Arecor Therapeutics Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Arecor The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220630 03:57:12